Resmed Inc RMD

NYSE US Health Care
$210.98 ▲ +1.16% (+$2.42)
Index member: S&P 500
📅 Earnings This Week
Open $206.72
Prev Close $208.56
Day Range $205.22 – $211.78
52W Range $180.27 – $293.81
Market Cap $30.60B
P/E (TTM) 20.08
Beta 0.75
Div Yield 1.15%
EPS (TTM) $10.37

📋 Company Profile

IndustryHealth Care
CountryUS
ExchangeNEW YORK STOCK EXCHANGE, INC.
CurrencyUSD
IPO Date1995-06-01
Shares Out.145,060,000
Websiteresmed.com/ ↗
Phone13026365400
Employees10,600
Revenue$1.43B
Gross Profit$898.8M
Net Income$398.7M
Free Cash Flow$1.75B
Total Assets$8.78B
Total Liabilities$2.29B
Equity$6.49B
About Resmed Inc

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Resmed Inc is a publicly traded company under the ticker symbol RMD on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

📊 Analyst Ratings

25 analysts (2026-07-01)

Strong Buy 4
Buy 10
Hold 9
Sell 1
Strong Sell 1

📰 Latest News for RMD

👥 Related Stocks